Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Research Field Genetics

Gut Feeling

| Phoebe Harkin

Twin study investigates how gut organisms influence the immune system

Research Field Diagnostics & prognostics

Pandemic Proteomics

An MS-based proteomics platform is painting a picture of variable patient responses to COVID-19

Research Field Drug discovery

A Model Experiment

| Audrey Dubourg

Can microphysiological systems help advance drug discovery?

Register to personalize your newsfeed

Create Account

Latest Articles

 Disease Area Infectious diseases

Rage Against the Dying of the Light

Sitting Down With… Jose Pulido, Larry A. Donoso Endowed Chair, Wills Eye
Research Field Drug discovery

Small, But Mighty

| Brent R Stockwell

Small-molecule inhibition of the SARS-CoV-2 viral protease may represent a promising route for therapy
Research Field Drug discovery

Time to Transform (Re)search and Development

The drug development system is broken; the COVID-19 pandemic is an opportunity to take a bold step towards accessible and affordable therapies.
Disease Area Infectious diseases

The COVID-19 Pandemic: A Summary

Expert pathologist Fred Plapp offers a summary of the virus causing COVID-19, its effects, and the pandemic’s evolving status
Disease Area Neurological

Getting on Target for Alzheimer’s

| Neil Cashman, James Kupiec

"Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity."
Tools & Techniques Clinical trials

A Framework for Translation

| Jonathan James

How strong partnerships can drive early-phase clinical trials
Tools & Techniques Diagnostics & prognostics

All the RAGE

| Luke Turner

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer
Research Field Neuroscience

A Better AD Model

| Brett Spangler

How primary neuronal cell cultures are unraveling the role of amyloid β oligomers in Alzheimer’s disease.
Research Field Pain & critical care

An Osteoarthritic Odyssey

Sitting Down With… Mike Clayman, CEO of Flexion Therapeutics, Inc., Burlington, Massachusetts, USA.
Research Field Cell & molecular biology

In the RNA

| Stephanie Sutton

RNA Inhibitors - an exciting avenue for drug development? We collate the findings from the Innovation that Matters series, hosted by WuXi Xpress...
All Articles

Latest Solutions

High precision and reproducible kinetic characterization and custom quantitation

| Contributed by ForteBio

Integrated workflow for rapid selection and optimization of hybridoma cell lines

| Contributed by ForteBio

Tools & Techniques Analytical science

A Fast and High Precision Influenza Vaccine Potency Assay

| Contributed by ForteBio

Tools & Techniques Analytical science

Top reasons to upgrade to a Q Exactive HF-X hybrid quadrupole-Orbitrap mass spectrometer

| Contributed by Thermo Fisher Scientific

All Solutions

Webinars on Demand

Tools & Techniques

Consistency, consistency - Automated Sample Prep for Translational Proteomics

| Sponsored by Thermo Fisher Scientific

High-throughput LC-MS workflows are essential in translational and clinical research proteomics.
Tools & Techniques Clinical trials

Multimodal molecular spectroscopy for medical diagnosis and therapy

| Sponsored by Andor

The webinar will look at efforts to translate researched multimodal spectroscopic approaches into automated systems with a high technology readiness level (TRL) for clinical applications.
Disease Area Omics

Monitoring Kinome Adaptations to Therapy using Quantitative High Resolution Mass Spectrometry

| Sponsored by Thermo Fisher Scientific

Learn how studying the kinome as a whole entity, can aide in understanding how tumors may evade current therapies by altering their kinome state.
All Webinars

Most popular articles

1. Disease Area Outcomes research

Efficacy vs Effectiveness

| William Aryitey

Tightly controlled efficacy studies can’t predict real-word effectiveness
2. Research Field Clinical trials

From Acne to MS

| Roisin McGuigan

A recent clinical trial finds a new use for an old antibiotic.
3. Research Field Cancer

No Biomarker, No Trial?

| James Ritchie, Sidath Katugampola, Paul Jones

The vast majority of experimental cancer drugs fail during the later stages of clinical development
4. Tools & Techniques Analytical science

The Hunt for an HD Blood Test

| Roisin McGuigan

Do we finally have an effective blood biomarker for studying progression of Huntington’s disease?
5. Outside the Lab Public health

Medical Robotics Are the Future

| Jeremy Russell

As healthcare systems across the globe feel the strain of an increasing (and aging) population, we need someone – or rather something – to lend a help

Disease Area

Infectious diseases

Rage Against the Dying of the Light

Sitting Down With… Jose Pulido, Larry A. Donoso Endowed Chair, Wills Eye
Infectious diseases

The COVID-19 Pandemic: A Summary

Expert pathologist Fred Plapp offers a summary of the virus causing COVID-19, its effects, and the pandemic’s evolving status

Research Field

Genetics

Gut Feeling

| Phoebe Harkin

Twin study investigates how gut organisms influence the immune system
Diagnostics & prognostics

Pandemic Proteomics

An MS-based proteomics platform is painting a picture of variable patient responses to COVID-19

Tools & Techniques

Clinical trials

A Framework for Translation

| Jonathan James

How strong partnerships can drive early-phase clinical trials
Diagnostics & prognostics

All the RAGE

| Luke Turner

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer

Outside the Lab

Public health

Picking up on the Subtler Signs of Brain Cancer

| Jonathan James

How early telltales of tumors are frequently missed by both patients and clinicians
Policy

Moving on from the Great CRISPR Controversy

| Jonathan James

How will the storm whipped up by He Juinkai’s flagrant disregard for medical ethics affect the wider ambitions of the gene-editing field?

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register

October Issue of The Translational Scientist